Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steen Stender

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Acta Dermato-Venereologica|February 22, 2014
Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasisPeter Jensen, Claus Zachariae, Robin Christensen, et al.
American Heart Journal|December 18, 2002
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemiaAnders G Olsson, Helge Istad, Olavi Luurila, et al.
Ugeskrift for Laeger|November 19, 2003
[The impact of sugar on health]Chistian Mølgaard, Niels Lyhne Andersen, Vibeke Barkholt, et al.
European Heart Journal. Cardiovascular Imaging|May 4, 2013
Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokersThomas Rasmussen, Lars Køber, Jesper Holst Pedersen, et al.
Plos One|December 25, 2013
No association between loss-of-function mutations in filaggrin and diabetes, cardiovascular disease, and all-cause mortalityLise Lotte N Husemoen, Tea Skaaby, Torben Jørgensen, et al.
Contact Dermatitis|January 25, 2013
Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitisJacob P Thyssen, Allan Linneberg, Katrine Ross-Hansen, et al.
Environment International|May 20, 2017
Exposure to phenols, parabens and UV filters: Associations with loss-of-function mutations in the filaggrin gene in men from the general populationUlla N Joensen, Niels Jørgensen, Jacob P Thyssen, et al.
Contact Dermatitis|July 2, 2013
Carriers of filaggrin gene (FLG) mutations avoid professional exposure to irritants in adulthoodJosefine Bandier, Katrine Ross-Hansen, Berit C Carlsen, et al.
Plos One|June 7, 2014
Associations of filaggrin gene loss-of-function variants and human papillomavirus-related cancer and pre-cancer in Danish adultsTea Skaaby, Lise Lotte N Husemoen, Torben Jørgensen, et al.
Atherosclerosis|July 17, 2007
Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistanceHerbert Schuster, Björn Fagerberg, Siôn Edwards, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Acta Dermato-Venereologica|February 22, 2014
Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasisPeter Jensen, Claus Zachariae, Robin Christensen, et al.
American Heart Journal|December 18, 2002
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemiaAnders G Olsson, Helge Istad, Olavi Luurila, et al.
Ugeskrift for Laeger|November 19, 2003
[The impact of sugar on health]Chistian Mølgaard, Niels Lyhne Andersen, Vibeke Barkholt, et al.
European Heart Journal. Cardiovascular Imaging|May 4, 2013
Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokersThomas Rasmussen, Lars Køber, Jesper Holst Pedersen, et al.
Plos One|December 25, 2013
No association between loss-of-function mutations in filaggrin and diabetes, cardiovascular disease, and all-cause mortalityLise Lotte N Husemoen, Tea Skaaby, Torben Jørgensen, et al.
Contact Dermatitis|January 25, 2013
Filaggrin mutations are strongly associated with contact sensitization in individuals with dermatitisJacob P Thyssen, Allan Linneberg, Katrine Ross-Hansen, et al.
Environment International|May 20, 2017
Exposure to phenols, parabens and UV filters: Associations with loss-of-function mutations in the filaggrin gene in men from the general populationUlla N Joensen, Niels Jørgensen, Jacob P Thyssen, et al.
Contact Dermatitis|July 2, 2013
Carriers of filaggrin gene (FLG) mutations avoid professional exposure to irritants in adulthoodJosefine Bandier, Katrine Ross-Hansen, Berit C Carlsen, et al.
Plos One|June 7, 2014
Associations of filaggrin gene loss-of-function variants and human papillomavirus-related cancer and pre-cancer in Danish adultsTea Skaaby, Lise Lotte N Husemoen, Torben Jørgensen, et al.
Atherosclerosis|July 17, 2007
Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistanceHerbert Schuster, Björn Fagerberg, Siôn Edwards, et al.
Pageof 11